3-Year follow-up after uniportal thoracoscopic sympathicotomy for hyperhidrosis: Undesirable side effects

KARAMUSTAFAOĞLU Y. A., KUZUCUOĞLU M., YANIK F., SAĞIROĞLU G., YÖRÜK Y.

Journal of Laparoendoscopic and Advanced Surgical Techniques, cilt.24, sa.11, ss.782-785, 2014 (SCI-Expanded, Scopus)

Özet

Objective: Endoscopic thoracic sympathectomy or sympathicotomy, for the treatment of palmar, axillary, and plantar hyperhidrosis, is generally performed at one or two levels, between T2 and T5. Compensatory sweating (CS) is a severe and undesirable side effect of this procedure. Here, we describe the success of treatment and degree of postoperative CS in sympathicotomy patients. Subjects and Methods: This study included 80 patients treated by uniportal (5-mm) thoracoscopic sympathicotomy (electrocautery) for primary hyperhidrosis over a 6-year period (2007-2013). Sympathicotomy was performed bilaterally at T2 for blushing (n = 2), T2-T3 for palmar-only hyperhidrosis (n = 34), T2-T4 for palmar and axillary hyperhidrosis (n = 39), and T3-T4 for axillary-only hyperhidrosis (n = 5). Outcome was assessed 2 weeks postsurgery at the clinic and annually thereafter by telephone questionnaire. Mean follow-up time was 35.2 ± 23.3 months. Questionnaires assessed patients' degree of sweating, postoperative CS, overall satisfaction, and complications. Results: Seventy-one patients (88.7%) were very satisfied, whereas only 9 (11.3%) were dissatisfied with the procedure. Complication incidence was 7.5%, and CS occurred in 77.5% of patients. Therapeutic success rate was 97.5%; complete relief of hyperhidrosis was achieved in 72 (90%) patients, whereas 8 (10%) experienced recurrence. Conclusions: CS is a frequent side effect of thoracoscopic sympathicotomy. We recommend all patients undergoing this procedure should be warned of the potential risk of developing severe CS.